Metastatic Hormone Refractory Prostate Cancer Recruiting Phase 1 Trials for Cefotaxime (DB00493)

Also known as: Metastatic hormone refractory Prostate cancer / Metastatic Prostate cancer / Prostate cancer metastatic / Metastatic Prostate Carcinoma / Carcinoma of the prostate metastatic / Prostatic cancer metastatic

DBCOND0036371 (Metastatic Hormone Refractory Prostate Cancer)Recruiting1 IdentifierTitlePurposeDrugs
NCT03873805PSCA-CAR T Cells in Treating Patients With Metastatic Castration Resistant Prostate CancerTreatment